SLING THERAPEUTICS: FIRST PATIENTS DOSED IN GLOBAL PHASE 3 ORBIT PIVOTAL TRIAL OF LINSITINIB FOR THYROID EYE DISEASE

Reuters · 2d ago

Please log in to view news